Table 2.
Imaging presentation of the study cohort.
| Variable, parameter | Unit or category | Total | Surgical remission | Response to first-generation SRLs | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Yes | No | p | Good | Poor | p | ||||||||
| N | Results | N | Results | N | Results | N | Results | N | Results | ||||
| Tumor imaging in MRI, n (%) | Microadenoma | 146 | 31 (21.2) | 58 | 23 (40.0) | 81 | 6 (7.4) | <0.001 | 35 | 5 (14.3) | 37 | 1 (2.7) | 0.102 |
| Macroadenoma | 115 (78.7) | 35 (60.0) | 75 (92.6) | 30 (85.7) | 36 (97.3) | ||||||||
| Maximal tumor diameter, Median [IQR] | mm | 124 | 19 [12-25] | 54 | 12.5 [9-19] | 64 | 23 [18-30] | <0.001 | 26 | 22 [16-28] | 32 | 25 [20-35] | 0.162 |
| Extrasellar expansion, n (%) | yes | 129 | 73 (56.6) | 48 | 14 (29.2) | 74 | 58 (78.4) | <0.001 | 30 | 18 (60.0) | 35 | 32 [91.4] | 0.003 |
| Compression of the optic chiasm, n (%) | yes | 122 | 31 (25.4) | 48 | 6 (12.5) | 67 | 25 (37.3) | 0.003 | 28 | 5 (17.9) | 32 | 19 (59.4) | 0.001 |
| Degree of cavernous sinus invasion, n (%) | None | 130 | 69 (53.1) | 53 | 44 (83.0) | 74 | 22 (29.7) | <0.001 | 30 | 12 (40.0) | 35 | 8 (22.9) | 0.043 |
| Unilateral | 47 (36.2) | 9 (17.0) | 38 (51.4) | 16 (53.3) | 17 (48.6) | ||||||||
| Bilateral | 14 (10.8) | 0 (0.0) | 14 (18.9) | 2 (6.7) | 10 (28.6) | ||||||||
The bold values are statistically significant.